Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Evidence summaries

View All
Belimumab for Systemic Lupus Erythematosus
Bendamustine for Patients with Indolent B Cell Lymphoid Malignancies Including Chronic Lymphocytic Leukaemia
Benzodiazepines Alone or in Combination with Antipsychotic Drugs for Acute Psychosis
Benzodiazepines for Alcohol Withdrawal
Benzodiazepines for Neuroleptic-Induced Tardive Dyskinesia
Beta2-Agonists for Acute Bronchitis
Beta2-Agonists for Exercise-Induced Asthma
Beta-Adrenergic Blocking Agents and Intermittent Claudication
Beta-Blockers, Calcium Antagonists, or Nitrates for Stable Angina
Beta-Blockers after Acute Myocardial Infarction
Beta-Blockers Against other Antihypertensive Drugs
Beta-Blockers as Second-Line Therapy for Primary Hypertension
Beta-Blockers for Essential Tremor
Beta-Blockers for Heart Failure
Beta-Blockers for Hypertension
Beta-Blockers for Hyperthyreoidism
Beta-Blockers for Mild to Moderate Hypertension in Pregnancy
Beta-Blockers in Patients Without Heart Failure after Myocardial Infarction
Beta-Blockers in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices
Betahistine for Ménière's Disease and Vertigo
Betamethasone for Idiopathic Thrombocytopenic Purpura during Pregnancy
Betamimetics for Preterm Labour
Interventions for Nail Psoriasis
Interventions for Nausea and Vomiting in Early Pregnancy
Interventions for Normal Tension Glaucoma
Interventions for Nutritional Support in Subacute Stroke
Interventions for Old World Cutaneous Leishmaniasis
Interventions for Oral Mucositis in Patients Receiving Treatment for Cancer
Interventions for Pain with Intrauterine Device Insertion
Interventions for Pemphigus